Molecule intelOpportunity: Moderate0Crowded market

Chloride

101 brands · 69 companies · product forms

2 DRAP alerts

Opportunity snapshot

Launch attractiveness
39
Market saturation
90
Price room
100
Regulatory risk
70
101
brands
69
companies
Rs 139.86
median price
120
price points
3,207.8x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 6%

Price room

Across observed sources and strengths
CheapestRs 2.1
MedianRs 139.86
Most expensiveRs 6,736.39
Spread3,207.8×
Sources: DRAP-official, DVAGO

max/min price ratio 3207.80x across 120 trusted points (Rs 2.1-6736.39). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Chloride — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2022-10-06
Suspension of Drug Registration: Tablets of Diclofenac Potassium in Strengths of 75mg and
Recall Alert: Drug Product; Fentos 50mg Tablets (Batch # 599) By M/s. Hisun Pharmaceutical

Why this score

Launch attractiveness

40% supply-gap(20) + 25% price-variation(100) + 20% low-competition(10) + 15% supply-disruption(40), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

69 canonical companies and 101 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 3207.80x across 120 trusted points (Rs 2.1-6736.39). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

2 DRAP alert(s), latest 2022-10-06 incl. recall/safety.

Confidence

Reduced by: no ATC code.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.